China's Top Departments: Hematology at Tangdu Hospital, Air Force Medical University

If you or a family member is living with leukemia, lymphoma, multiple myeloma, or a bone-marrow failure disorder — or you are evaluating hematopoietic stem cell transplantation abroad — the Department of Hematology at Tangdu Hospital in Xi'an deserves a place on your shortlist. As the clinical home of one of the hospital's signature techniques, the department offers a comprehensive transplantation-centered system of care that is particularly accessible for patients from Central Asia, Southeast Asia and the wider international community.

At Medora, we help international patients navigate treatment at Tangdu and other leading Chinese centers. Here is what you need to know.

About the Hospital

Tangdu Hospital — the Second Affiliated Hospital of the Air Force Medical University of the Chinese PLA — traces its origins to 1939 in Yan'an and today ranks among the largest military-affiliated general hospitals in northwest China. The hospital covers 241,000 m² with 3,251 beds and 46 specialty departments, handling over 2 million outpatient and emergency visits, 80,000 surgeries and 130,000 admissions annually. It hosts 4 national key disciplines, 3 national key (cultivation) disciplines, 3 PLA medical research institutes and 8 PLA medical specialty (disease) centers, and is equipped with a 7.0T MRI, PET/MR and a fourth-generation da Vinci surgical robot.

Among the hospital's well-known signature techniques, it lists hematopoietic stem cell transplantation and molecule-targeted therapy combined with transplantation for advanced chronic myeloid leukemia — both delivered clinically by the Department of Hematology.

About the Department

The Department of Hematology is one of the key departments in Tangdu Hospital's internal medicine system and the clinical department behind the hospital's signature technique of hematopoietic stem cell transplantation. Integrating clinical care, teaching and research, it covers:

• Leukemia — acute and chronic forms
• Lymphoma — Hodgkin and non-Hodgkin lymphoma
• Multiple myeloma and other plasma cell disorders
• Anemia and bone-marrow failure disorders such as aplastic anemia
• Bleeding and clotting disorders such as immune thrombocytopenic purpura (ITP)

Department leadership includes Liu Li (刘立), Director of the Department of Hematology, chief physician and professor; Liu Qiang (刘强), Deputy Director, MD, in charge of the transplantation ward; Hao Miaowang (郝淼旺), associate chief physician and associate professor; and Hao Jie (郝婕), chief physician and professor.

Academic Standing

• Core department for a hospital signature technique: hematopoietic stem cell transplantation is listed among Tangdu Hospital's well-known signature techniques, and the Department of Hematology is its core clinical department. The department also performs molecule-targeted therapy combined with transplantation for advanced chronic myeloid leukemia, another hospital signature technique.
• Military and platform backing: the department is supported by the Air Force Medical University (formerly the Fourth Military Medical University), within a hospital that hosts national key disciplines, PLA medical research institutes and PLA medical specialty (disease) centers — of which internal medicine, including hematology, is an important part.
• Technical system: a comprehensive diagnostic and treatment system centered on hematopoietic stem cell transplantation and covering leukemia, lymphoma, multiple myeloma, bone-marrow failure disorders and bleeding/clotting disorders.
• Overall ranking reference: on the Fudan-style ranking displayed by the Youlai Doctor platform, Tangdu Hospital ranks 98th nationwide overall. This is a platform-displayed figure; for authoritative data, please defer to the official Fudan "China Hospital Rankings" release.

Core Techniques

Hematopoietic Stem Cell Transplantation (HSCT) — The Signature

HSCT is the department's core signature technique. The department performs autologous transplantation and, building on this foundation, focuses on allogeneic transplantation, including haploidentical (half-matched) transplantation, run by a dedicated transplantation ward led by Deputy Director Liu Qiang.

What this means for you: haploidentical transplantation dramatically expands donor options — a parent, child or sibling can often serve as a half-matched donor — which matters greatly for international patients without a fully matched related donor in a registry.

Targeted Therapy Plus Transplantation for Advanced CML

Molecule-targeted therapy combined with transplantation for advanced chronic myeloid leukemia (CML) is one of Tangdu Hospital's listed signature techniques, offering a pathway for patients whose disease has progressed beyond first-line tyrosine kinase inhibitor control.

Leukemia Care

Standardized and individualized treatment of acute and chronic leukemia, with transplantation evaluation built into the care pathway.

Lymphoma Care

Standardized diagnosis and treatment of Hodgkin and non-Hodgkin lymphoma. For relapsed/refractory lymphoma, the department develops individualized regimens combining chemotherapy, targeted therapy, immunotherapy and CAR-T cell therapy.

Multiple Myeloma

Standardized and individualized treatment of multiple myeloma and related plasma cell disorders.

Anemia and Bone-Marrow Failure Disorders

Diagnosis and individualized treatment of aplastic anemia and related conditions.

Bleeding and Clotting Disorders

Diagnosis and treatment of conditions such as immune thrombocytopenic purpura (ITP).

Expert Team

• Prof. Liu Li (刘立), Department Director: chief physician, professor, postgraduate supervisor, MD. National youth committee member of the Chinese Society of Hematology, youth committee member of the PLA Hematology Society, vice chair of the Shaanxi Medical Association Hematology Branch, and vice chair of the Shaanxi Medical Association Clinical Immunology Branch. Specializes in the treatment of leukemia, lymphoma and aplastic anemia, and in hematopoietic stem cell transplantation for malignant blood diseases.
• Dr. Liu Qiang (刘强), Deputy Director: MD and lecturer; responsible for the hematopoietic stem cell transplantation ward and, building on autologous transplantation, focuses on allogeneic hematopoietic stem cell transplantation.
• Dr. Hao Miaowang (郝淼旺): associate chief physician, associate professor, MD. Standing committee member of the Shaanxi Medical Association Hematology Society, standing committee member of the Shaanxi Hematopoietic Stem Cell Transplantation Society, and standing committee member of the Lymphoma Society of the Shaanxi Anti-Cancer Association. Specializes in the diagnosis and individualized treatment of malignant blood diseases such as leukemia, lymphoma and multiple myeloma, as well as aplastic anemia.
• Prof. Hao Jie (郝婕): chief physician, professor; vice chair of the Shaanxi Medical Association Hematology Branch and committee member of the Hematology-Oncology Committee of the Chinese Anti-Cancer Association. Focuses on lymphoma and develops individualized regimens combining chemotherapy, targeted therapy, immunotherapy and CAR-T cell therapy for relapsed/refractory lymphoma.

Note: expert titles and clinic schedules are subject to the hospital's official announcements on the day.

Conditions Suitable for Referral

• Acute/chronic leukemia, including patients who need evaluation for hematopoietic stem cell transplantation
• Lymphoma (Hodgkin and non-Hodgkin), including relapsed/refractory cases
• Multiple myeloma and other plasma cell disorders
• Myelodysplastic syndromes (MDS)
• Bone-marrow failure disorders such as aplastic anemia
• Anemias of various causes (iron-deficiency, hemolytic, etc.)
• Bleeding and clotting disorders: immune thrombocytopenic purpura, hemophilia, etc.
• Malignant blood diseases requiring autologous or allogeneic (including haploidentical) hematopoietic stem cell transplantation

Address and Contact

Tangdu Hospital, Air Force Medical University No. 1 Xinsi Road, Baqiao District, Xi'an, Shaanxi, China Tel: +86-29-84777777 (main line / inquiries / appointments); +86-29-84777114 (directory assistance) Website: tdwww.fmmu.edu.cn

Getting there: international patients typically fly into Xi'an Xianyang International Airport (XIY); the hospital in Baqiao District is about 40 minutes by car. Bus lines 42, 508, 401 and 416 stop at "Tangdu Hospital", and Metro Line 1 (Fangzhicheng Station) is within walking distance.

Language support: the hospital routinely receives international patients and can arrange medical interpreters for English-, Russian- and Arabic-speaking patients. International patients may request a remote consultation and submit medical records and imaging before travelling. Please confirm arrangements through the hospital's official channels.

---

At Medora, we specialize in connecting international patients with China's top hematology and transplant centers. If you're considering treatment at Tangdu Hospital, contact us for a free consultation and second opinion. You may also be interested in our guides to hematology at Ruijin Hospital and thoracic surgery at Tangdu.